Thomas J. Herzfeld Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-944
| Closed | -$85.8K | – | 277 |
|
|
2023
Q3 | $85.8K | Buy |
944
+126
| +15% | +$11.5K | 0.03% | 110 |
|
|
2023
Q2 | $66.2K | Buy |
818
+40
| +5% | +$3.24K | 0.03% | 109 |
|
|
2023
Q1 | $61.9K | Sell |
778
-328
| -30% | -$26.1K | 0.03% | 99 |
|
|
2022
Q4 | $74.8K | Sell |
1,106
-376
| -25% | -$25.4K | 0.03% | 98 |
|
|
2022
Q3 | $74K | Buy |
1,482
+60
| +4% | +$3K | 0.03% | 94 |
|
|
2022
Q2 | $79K | Sell |
1,422
-432
| -23% | -$24K | 0.03% | 101 |
|
|
2022
Q1 | $103K | Buy |
1,854
+356
| +24% | +$19.8K | 0.04% | 106 |
|
|
2021
Q4 | $84K | Buy |
1,498
+608
| +68% | +$34.1K | 0.03% | 125 |
|
|
2021
Q3 | $43K | Buy |
890
+770
| +642% | +$37.2K | 0.02% | 143 |
|
|
2021
Q2 | $5K | Buy |
120
+32
| +36% | +$1.33K | ﹤0.01% | 271 |
|
|
2021
Q1 | $3K | Hold |
88
| – | – | ﹤0.01% | 308 |
|
|
2020
Q4 | $3K | Hold |
88
| – | – | ﹤0.01% | 268 |
|
|
2020
Q3 | $3K | Buy |
88
+26
| +42% | +$886 | ﹤0.01% | 221 |
|
|
2020
Q2 | $2K | Buy |
+62
| New | +$2K | ﹤0.01% | 276 |
|
|
2015
Q3 | – | Sell |
-812
| Closed | -$22K | – | 333 |
|
|
2015
Q2 | $22K | Buy |
+812
| New | +$22K | 0.01% | 243 |
|